5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
McKesson Europe AG's 5-Year ROIIC % for the quarter that ended in Mar. 2022 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for McKesson Europe AG's 5-Year ROIIC % or its related term are showing as below:
CAKFY's 5-Year ROIIC % is not ranked *
in the Medical Distribution industry.
Industry Median: 6.37 * Ranked among companies with meaningful 5-Year ROIIC % only.
McKesson Europe AG 5-Year ROIIC % Historical Data
The historical data trend for McKesson Europe AG's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of McKesson Europe AG's 5-Year ROIIC %
For the Medical Distribution subindustry, McKesson Europe AG's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
McKesson Europe AG's 5-Year ROIIC % Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where McKesson Europe AG's 5-Year ROIIC % falls into.
McKesson Europe AG 5-Year ROIIC % Calculation
McKesson Europe AG's 5-Year ROIIC % for the quarter that ended in Mar. 2022 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
McKesson Europe AG (OTCPK:CAKFY) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
McKesson Europe AG 5-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of McKesson Europe AG's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
McKesson Europe AG (McKesson Europe AG) Business Description
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CAKFY has been successfully added to your 